Sarah Stanley

Sarah Stanley, PhD, serves as an Associate Professor at the University of California, Berkeley with dual appointments in the Department of Molecular and Cell Biology (Division of Immunology and Molecular Medicine) and the School of Public Health (Division of Infectious Disease and Vaccinology). Her research confronts tuberculosis as a leading global infectious killer through investigations into pathogenesis, immunity, and therapeutic development, while extending to emerging threats like SARS-CoV-2.

Her educational foundation includes a PhD in Microbiology and Immunology from the University of California, San Francisco (2006).

Dr. Stanley's work centers on tuberculosis mechanisms, including pathogen immune subversion, host metabolic interactions, and protective immunity. She pioneers novel therapeutics and vaccines while championing scientific capacity building in East Africa through the Alliance for Global Health and Science, which she founded and directs. Her research bridges fundamental molecular insights with global health applications.

Analysis of her 2021-2023 publications reveals dual thematic trajectories: tuberculosis-focused studies examining neutrophil function, HIF-1α signaling, and drug resistance mechanisms, alongside high-impact SARS-CoV-2 research spanning viral entry, antiviral therapeutics, and CRISPR-based diagnostics. This integration of chronic and emerging infectious disease research underscores her translational approach.

Scientific Awards:

• Distinguished Teaching Award from UC Berkeley (2025)

As founder and director of the Alliance for Global Health and Science, Dr. Stanley spearheads workshop-based capacity strengthening across East Africa. Her 2022 publication details this scalable model for research training in resource-limited settings, reflecting her commitment to equitable scientific advancement beyond laboratory discoveries.